![]() |
市場調查報告書
商品編碼
1495441
劑量監測設備市場:按類型、應用分類 - 2024-2030 年全球預測Dose Monitoring Device Market by Type (Active, Passive), Application (Computed Radiography, Fluoroscopy & Interventional Imaging, Mammography) - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
劑量監測設備市場規模預估2023年為33.2億美元,2024年達36億美元,預估2030年將達59.2億美元,複合年成長率為8.62%。
劑量監測設備是複雜的技術工具,旨在準確測量和追蹤患者在診斷成像期間接受的輻射劑量。劑量監測設備在最大限度地減少不必要的輻射暴露、遵守放射照相中的「盡可能低」(ALARA) 原則以及確保病患安全方面發揮著重要作用。劑量監測設備可與各種影像設備(例如 CT 掃描儀、X 光機和乳房X光攝影攝影機)整合,為醫護人員提供即時資料和警報。這可以最佳化成像通訊協定,以確保每位患者接受準確診斷所需的精確輻射劑量,同時最大限度地降低健康風險。越來越多的慢性疾病需要精準醫療,以及擴大採用先進的醫療技術,正在推動劑量監測設備市場的成長。然而,與現有醫療IT基礎設施整合相關的技術複雜性阻礙了劑量監測設備的採用。增強與電子健康記錄(EHR) 的互通性以及用於資料管理和分析的開拓SaaS(軟體即服務)平台為劑量監測設備市場的成長提供了有利可圖的機會。
主要市場統計 | |
---|---|
基準年[2023] | 33.2億美元 |
預測年份 [2024] | 36億美元 |
預測年份 [2030] | 59.2億美元 |
複合年成長率(%) | 8.62% |
區域洞察
在美洲,特別是在美國和加拿大,不斷上漲的醫療保健成本、技術進步以及對病人安全的重視正在推動劑量監測設備的創新和採用。嚴格的法規和患者意識提升計劃進一步推動了美國對劑量監測設備的需求。加拿大劑量監測設備市場受到該國注重患者安全和用藥準確性的醫療保健政策的推動。政府對醫療保健提供者採用數位醫療技術的獎勵值得注意。在亞太地區,醫療保健投資的迅速增加和用藥安全意識的提高正在推動對劑量監測設備的需求。由於醫療基礎設施的大量投資和製藥行業的蓬勃發展,中國劑量監測設備的採用率不斷增加。在日本,隨著人口老化和慢性病數量的增加,精準醫療的需求不斷增加。這一趨勢凸顯了對先進劑量監測設備的迫切需求,以確保準確和個人化的治療方法。在印度,快速的都市化和醫療改革正在推動對劑量監測設備的需求。歐盟國家透過醫療設備法規 (MDR) 等統一法規強調劑量監測設備的高品質和安全標準。由於對醫療基礎設施的策略性投資和對慢性病管理的日益重視,中東地區正在經歷成長。非洲劑量監測設備市場對醫療基礎設施的投資不斷增加,為未來的成長奠定了基礎。
FPNV定位矩陣
FPNV 定位矩陣對於評估劑量監測設備市場供應商的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對劑量監測設備市場供應商的當前狀態進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對劑量監測設備市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[182 Pages Report] The Dose Monitoring Device Market size was estimated at USD 3.32 billion in 2023 and expected to reach USD 3.60 billion in 2024, at a CAGR 8.62% to reach USD 5.92 billion by 2030.
A dose monitoring device is an advanced technological tool designed for accurately measuring and tracking the radiation doses a patient receives during diagnostic imaging procedures. The dose monitoring devices play a crucial role in ensuring patient safety by minimizing exposure to unnecessary radiation, thereby adhering to the principle of "As Low As Reasonably Achievable" (ALARA) in radiographic practices. Dose monitoring devices can be integrated with various imaging equipment, such as CT scanners, X-ray machines, and mammography units, providing real-time data and alerts to healthcare professionals. This enables the optimization of imaging protocols, ensuring that each patient receives the precise amount of radiation required for accurate diagnosis while minimizing health risks. The rising incidences of chronic diseases requiring precision medicine and the increasing adoption of advanced healthcare technologies are driving the growth of the dose-monitoring device market. However, technical complexities associated with integration into existing healthcare IT infrastructures hinder the adoption of dose-monitoring devices. Enhancing interoperability with electronic health records (EHRs) and developing software-as-a-service (SaaS) platforms for data management and analysis offer remunerative opportunities for the growth of the dose monitoring device market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.32 billion |
Estimated Year [2024] | USD 3.60 billion |
Forecast Year [2030] | USD 5.92 billion |
CAGR (%) | 8.62% |
Regional Insights
In the Americas, especially in the United States and Canada, there has been innovation and adoption of dose monitoring devices due to high healthcare expenditure, technological advancements, and a strong emphasis on patient safety. The need for dose monitoring devices in the U.S. is further bolstered by stringent regulations and patient awareness programs. Canada's dose monitoring device market is driven by national healthcare policies focusing on patient safety and medication accuracy. Government incentives for healthcare providers to adopt digital health technologies are notable. The surge in healthcare investments and a rising awareness of medication safety propel demand for dose monitoring devices in the Asia-Pacific region. China is witnessing an increase in the adoption of dose monitoring devices with considerable investments in healthcare infrastructure and a booming pharmaceutical industry. The need for precision medicine is rising in Japan, driven by an aging population and the increasing prevalence of chronic diseases. This trend underscores the critical need for advanced dose monitoring devices to ensure accurate and individualized treatment regimens. Rapid urbanization and healthcare reform drive demand for dose monitoring devices in India. The EU countries are highlighted by their unified regulations, including the Medical Devices Regulation (MDR), which emphasizes high quality and safety standards for dose monitoring devices. The Middle East region is witnessing growth through strategic investments in healthcare infrastructure and a growing emphasis on chronic disease management. The African dose monitoring device market showcases increasing investments in healthcare infrastructure, laying the groundwork for future growth.
Market Insights
The market dynamics represent an ever-changing landscape of the Dose Monitoring Device Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Dose Monitoring Device Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Dose Monitoring Device Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Dozee introduces ambulatory connected patient monitoring system Dozee Pro Ex'
Dozee introduced Dozee Pro Ex, an ambulatory-connected patient monitoring system designed in India for global usage, signifying a major leap in continuous healthcare monitoring. This advanced system is empowered with wireless wearable sensors for relentless tracking of vital signs such as ECG rhythm, blood pressure, heart rate, oxygen saturation, respiration rate, and temperature. Notably, it integrates an AI-enhanced early warning system that diligently analyzes vital parameter trends, offering prompt notifications of potential clinical deteriorations. This technology enables healthcare providers to efficiently monitor patients - whether in bed, moving within hospital premises, or at home - through a centralized control center and dedicated mobile applications for medical professionals. [Published On: 2023-10-06]
FDA Approves LEQEMBI (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer's Disease
In a significant advancement for Alzheimer's disease treatment, the U.S. Food and Drug Administration (FDA) has granted accelerated approval for LEQEMBI (lecanemab-irmb) 100 mg/mL injection, as announced by Eisai Co., Ltd. and Biogen Inc. This humanized monoclonal antibody, aimed at both soluble and insoluble amyloid beta formations characteristic of Alzheimer's, has shown promise in reducing the accumulation of amyloid beta plaques in the brain, a core feature of the disease. Indicated for patients with mild cognitive impairment or mild dementia stages of Alzheimer's, LEQEMBI necessitates careful patient selection and monitoring, especially for amyloid-related imaging abnormalities (ARIA). [Published On: 2023-01-06]
Tracerco announces launch of next generation personal electronic dosimeter range - Tracerco PED2
Tracerco introduced advancement in personal radiation safety; the PED2 dosimeters embody Tracerco's patented detection technology, propelling its legacy of excellence in active dosimetry. The PED2 series, a refined version of the acclaimed PED range, offers superior radiological safety management, especially in demanding conditions. Simon Lambert, Tracerco's Technology Manager, highlights the product's enhanced usability, management ease, and development in collaboration with seasoned users, ensuring an extraordinary market offering. [Published On: 2022-03-29]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Dose Monitoring Device Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Dose Monitoring Device Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Bracco S.p.A., Canon Inc., Dozee, Fuji Electric Co., Ltd., Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Guerbet, IBA Dosimetry GmbH, Infab Corporation, INFINITT Healthcare Co., Ltd., Koninklijke Philips N.V., LANDAUER, Inc. by Fortive Corporation, Medic Vision, Medsquare, Mirion Technologies, Inc., Novarad Corporation, PACSHealth, LLC, QAELUM NV, RaySafe by Fluke Corporation, Sectra AB, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., and Volpara Health Limited.
Market Segmentation & Coverage